|
⚲
|
| Keyboard |
| Aquamarine Financial Cayman Ltd
✚
|
|
|---|---|
| CRD # | 335337 |
| SEC # | 801-136110 |
| CIK # | 0002104187 |
| AUM | 5,761.5 M (2026-06-03) |
| Employees | 5 (40% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 345-745-2782 |
| Address | c/o Zedra Fund Administration Cayman Ltd Grand Cayman, Cayman Islands |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0002104187 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bank Bradesco | 588.7 | ||
| YPF Sociedad Anonima | 417.2 | ||
| Grupo Financiero Galicia Sa | 110.7 | ||
| Gerdau Sa | 60.4 | ||
| Banco Santander Brasil Sa | 58.2 | ||
| Macro Bank Inc | 41.2 | ||
| Proshares Trust II | 28.3 | ||
| BBVA Banco Frances Sa | 19.8 | ||
| Nu Holdings Ltd | 14.4 | ||
| Cosan Sa | 8.6 | ||
| Oramed Pharmaceuticals Inc | 7.2 | ||
| Alpha TAU Medical Ltd | 5.1 | ||
| Innoviz Technologies Ltd | 3.3 | ||
| Pulsenmore Ltd | 1.2 | ||
| Gas Transporter of the South Inc | 1.0 | ||
| Central Puerto Sa | 0.3 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Aquamarine Credit Fund Ltd | [2025-02-28] | 28.5 M | 1,993.0 M |
| Filed 2025-11-13 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 3.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 4 | 2.4 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 5.8 |
| By Discretionary | ||
| Discretionary | 7 | 5.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 5.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 5.7 | |
| United States Persons | 0.1 | |
| Total | 7 | 5.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| James Macfee | Director | 17 | 6 | |
| Gwendolyn McLaughlin | Director | 15 | 4 | |
| Randal Daije | Director | 14 | 2 | |
| Rafael Elias | Director | 13 | 2 | |
| John Doherty | Director | 12 | 2 | |
| Aquamarine Financial Ltd | Promoter | 1 | 1 | |
| Fernando Rivera Garcia-Lomas | Director | 1 | 1 | |
| Aquamarine Financial Cayman Ltd | Promoter | 1 | 1 | |
| Xavier Rahm | Director | 1 | 1 | |
| David van Duynhoven | Director | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002104187] | |
| SC 13G | [0002104187] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Aquamarine Financial Cayman Ltd | Oramed Pharmaceuticals Inc | [2026-05-15] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 9845009CD98AFD0E6879 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Complus Asset Management Limited
✚
|
5,866.6 M | |
|
Complus Asset Management Singapore PTE Ltd
✚
|
5,866.6 M | |
|
Aikya Investment Management Limited
✚
|
5,847.2 M | |
|
The Linonia Partnership LP
✚
|
NY | 5,836.4 M |
|
Millstreet Capital Management LLC
✚
|
MA | 5,821.3 M |
|
Trium Capital LLP
✚
|
5,790.8 M | |
|
Oasis Investment Strategies LLC
✚
|
IL | 5,727.6 M |
|
Leadenhall Capital Partners LLP
✚
|
5,715.9 M | |
|
Metis Global Partners LLC
✚
|
CA | 5,668.9 M |
|
Altarock Partners LP
✚
|
FL | 5,663.8 M |